Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer-A Secondary Analysis of the PET Plan Trial

Cancers
Eleni GkikaUrsula Nestle

Abstract

(1) Background: The optimal chemotherapy (CHT) regimen for concurrent chemoradiation (cCRT) is not well defined. In this secondary analysis of the international randomized PET-Plan trial, we evaluate the efficacy of different CHT. (2) Methods: Patients with inoperable NSCLC were randomized at a 1:1 ratio regarding the target volume definition and received isotoxically dose-escalated cCRT using cisplatin 80 mg/m2 (day 1, 22) and vinorelbin 15 mg/m2 (day 1, 8, 22, 29) (P1) or cisplatin 20 mg/m2 (day 1-5, 29-33) and vinorelbin 12.5 mg/m2 (day 1, 8, 15, 29, 36, 43) (P2) or carboplatin AUC1 (day 1-5, 29-33) and vinorelbin 12.5 mg/m2 (day 1, 8, 15, 29, 36, 43) (P3) or other CHT at the treating physician's discretion. (3) Results: Between 05/2009 and 11/2016, 205 patients were randomized and 172 included in the per-protocol analysis. Patients treated in P1 or P2 had a better overall survival (OS) compared to P3 (p = 0.015, p = 0.01, respectively). Patients treated with carboplatin had a worse OS compared to cisplatin (HR 1.78, p = 0.03), but the difference did not remain significant after adjusting for age, ECOG, cardiac function creatinine and completeness of CHT. (4) Conclusions: Carboplatin doublets show no significant difference c...Continue Reading

References

May 30, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Lokich, N Anderson
Aug 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathy S AlbainRobert B Livingston
Jun 27, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Paola MazzantiTullio Battelli
Jul 3, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frank FossellaChandra P Belani
Aug 21, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Petr ZatloukalMilan Kůta
Dec 31, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Adriano PaccagnellaUNKNOWN GSTVP (Gruppo di Studio Tumori Polmonari del Veneto)
Aug 25, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katsuyuki HottaMitsune Tanimoto
Feb 25, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giannicola D'AddarioFrances A Shepherd
Apr 30, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C P BelaniR B Natale
Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pierre FournelUNKNOWN Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie
Feb 28, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A AupérinUNKNOWN Meta-Analysis of Cisplatin/carboplatin based Concomitant Chemotherapy in non-small cell Lung Cancer (MAC3-LC) Group
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
May 9, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Jingwei JiangZhaohui Chu
Jun 7, 2007·Journal of the National Cancer Institute·Andrea ArdizzoniUNKNOWN CISCA (CISplatin versus CArboplatin) Meta-analysis Group
Apr 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karen KellyDavid R Gandara
May 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark A SocinskiEverett E Vokes
May 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Pierre PignonUNKNOWN LACE Collaborative Group
Aug 23, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D De RuysscherP Lambin
Feb 20, 2009·Current Treatment Options in Oncology·Rachel E Sanborn
Sep 10, 2011·Journal of the National Cancer Institute·Walter J CurranJames D Cox
Mar 16, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Luhua WangXiangru Zhang
Jun 12, 2012·International Journal of Radiation Oncology, Biology, Physics·David A PalmaGeorge Rodrigues
Aug 26, 2014·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Nicole EzerJuan Wisnivesky
Nov 26, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rafael Santana-DavilaJeffrey Whittle
Jan 7, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wilfried Ernst Erich Eberhardt
Oct 4, 2018·The New England Journal of Medicine·Scott J AntoniaUNKNOWN PACIFIC Investigators
Aug 27, 2019·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Frank GriesingerSarah M Goring
Dec 6, 2019·Journal of the National Comprehensive Cancer Network : JNCCN·David S EttingerMiranda Hughes
Jan 14, 2020·The Cochrane Database of Systematic Reviews·Vitor F VasconcellosRachel Riera
Oct 1, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D PlanchardUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Jul 1, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P E PostmusUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

❮ Previous
Next ❯

Citations

Jul 27, 2021·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Eleni GkikaUrsula Nestle

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00697333

Software Mentioned

SAS
Plan
R
ESPATÜ
PET

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.